Oxygen-carbon nanotubes as a chemotherapy sensitizer for paclitaxel in breast cancer treatment.
To study the in vivo and in vitro effects of adding oxygen carbon nanotubes (CNTs) to chemotherapy for breast cancer.MCF-7 and SK-BR-3 breast cancer cells were co-cultured with paclitaxel and then exposed to oxygen-CNTs under hypoxic conditions. Cell proliferation, viability, and apoptosis rate were...
Main Authors: | Yongkun Wang, Chuanying Wang, Yijun Jia, Xianhua Cheng, Qing Lin, Mingjie Zhu, Yunshu Lu, Longlong Ding, Ziyi Weng, Kejin Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4121325?pdf=render |
Similar Items
-
An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts.
by: Qing Chen, et al.
Published: (2017-01-01) -
Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (-paclitaxel) in metastatic breast cancer: which benefit for which patients?
by: Raffaella Palumbo, et al.
Published: (2016-05-01) -
miR-107 enhances the sensitivity of breast cancer cells to paclitaxel
by: Ma Changpo, et al.
Published: (2019-06-01) -
A systematic review and meta-analysis of nab-paclitaxel mono-chemotherapy for metastatic breast cancer
by: Haili Lu, et al.
Published: (2021-07-01) -
Recurring radiation-induced angiosarcoma of the breast that was treated with paclitaxel chemotherapy: a case report
by: Yoko Suzuki, et al.
Published: (2020-01-01)